FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280747130> ?p ?o ?g. }

• W2280747130 endingPage "21" @default.
• W2280747130 startingPage "516" @default.
• W2280747130 abstract "The aim of this study was to establish a standard protocol for detection of EGFR mutations in cytologic specimens.287 cytologic samples were collected from the patients who were suspected of having lung cancer at six hospitals in Beijing. A detection protocol for EGFR mutations was designed. Two comparative experiments were carried out for the coincidence in EGFR mutation rates between direct sequencing (Seq) and amplification refractory mutation system (ARMS) methods, and between 40 matched cytologic samples with formaldehyde-fixed paraffin embedded (FFPE) cytologic blocks and cytospin slides.Tumor cells were found in 236 out of 287 cases (82.2%, 236/287) . Among them, there were 31 cases (13.1%, 31/236) of low tumor cell content samples and 205 cases (86.9%, 205/236) of high tumor cell content samples. 180 cases in the high tumor cell content samples (87.8%, 180/205) were diagnosed to be consistent with NSCLC. 25 out of 194 cases were ruled out or indefinite to be diagnosed as NSCLC by immunohistochemistry. By direct sequencing, the mutation rate of EGFR was 27.8% (50/180) in NSCLC samples and 28.2% (50/177) in adenocarcinoma samples (high tumor content samples) . By ARMS, the mutation rate of EGFR was 45.6% (82/180) in NSCLC samples and 46.3% (82/177) in adenocarcinoma samples (high tumor content samples). The EGFR mutation rate in low tumor content samples was 38.7% (12/31) , there was no significant difference in EGFR mutation rates between the groups of low tumor cell content samples and high tumor cell content samples (P = 0.12). The concordance rate of EGFR mutation rates was 100% between scraping tumor cells from slides samples and from FFEP blocks in the 40 matched samples. Forty-eight out of 180 definitive NSCLC patients received Gefitinib therapy. The FPS was 12 months in the gefitinib-treated ARMS⁺ group and 2 months in the ARMS⁻ group (P < 0.001), and the OS was 19 months in the gefitinib-treated ARMS⁺ group and 7 months in the ARMS⁻ group (P = 0.003), but no significant differences were found in the efficacy (PFS and OS) of Gefitinib between Seq⁺ and Seq⁻ groups (P = 0.227, P = 0.510, respectively), and Seq⁺/ARMS⁺ and Seq⁻/ARMS⁺ groups (P = 0.354, P = 0.334, respectively).The detection protocol for EGFR mutations in cytological specimens introduced in this study is tested to be reliable and feasible. Pathological evaluation and immunohistochemistry are important in the detection procedure of EGFR mutations in cytologic specimens. High sensitivity methods should be selected for detection of EGFR mutations in cytologic samples." @default.
• W2280747130 created "2016-06-24" @default.
• W2280747130 creator A5008382997 @default.
• W2280747130 creator A5012705262 @default.
• W2280747130 creator A5015022724 @default.
• W2280747130 creator A5016839838 @default.
• W2280747130 creator A5019415245 @default.
• W2280747130 creator A5022755556 @default.
• W2280747130 creator A5047563854 @default.
• W2280747130 creator A5052267876 @default.
• W2280747130 creator A5053708169 @default.
• W2280747130 creator A5058965019 @default.
• W2280747130 creator A5066716873 @default.
• W2280747130 creator A5069028088 @default.
• W2280747130 creator A5073186065 @default.
• W2280747130 creator A5080254294 @default.
• W2280747130 creator A5087444786 @default.
• W2280747130 date "2014-07-01" @default.
• W2280747130 modified "2023-10-14" @default.
• W2280747130 title "[A standard protocol for detection of EGFR mutations in cytologic specimens]." @default.
• W2280747130 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25327657" @default.
• W2280747130 hasPublicationYear "2014" @default.
• W2280747130 type Work @default.
• W2280747130 sameAs 2280747130 @default.
• W2280747130 citedByCount "2" @default.
• W2280747130 countsByYear W22807471302016 @default.
• W2280747130 countsByYear W22807471302017 @default.
• W2280747130 crossrefType "journal-article" @default.
• W2280747130 hasAuthorship W2280747130A5008382997 @default.
• W2280747130 hasAuthorship W2280747130A5012705262 @default.
• W2280747130 hasAuthorship W2280747130A5015022724 @default.
• W2280747130 hasAuthorship W2280747130A5016839838 @default.
• W2280747130 hasAuthorship W2280747130A5019415245 @default.
• W2280747130 hasAuthorship W2280747130A5022755556 @default.
• W2280747130 hasAuthorship W2280747130A5047563854 @default.
• W2280747130 hasAuthorship W2280747130A5052267876 @default.
• W2280747130 hasAuthorship W2280747130A5053708169 @default.
• W2280747130 hasAuthorship W2280747130A5058965019 @default.
• W2280747130 hasAuthorship W2280747130A5066716873 @default.
• W2280747130 hasAuthorship W2280747130A5069028088 @default.
• W2280747130 hasAuthorship W2280747130A5073186065 @default.
• W2280747130 hasAuthorship W2280747130A5080254294 @default.
• W2280747130 hasAuthorship W2280747130A5087444786 @default.
• W2280747130 hasConcept C104317684 @default.
• W2280747130 hasConcept C121608353 @default.
• W2280747130 hasConcept C126322002 @default.
• W2280747130 hasConcept C142724271 @default.
• W2280747130 hasConcept C18823058 @default.
• W2280747130 hasConcept C204232928 @default.
• W2280747130 hasConcept C2776256026 @default.
• W2280747130 hasConcept C2781182431 @default.
• W2280747130 hasConcept C2908647359 @default.
• W2280747130 hasConcept C501734568 @default.
• W2280747130 hasConcept C54355233 @default.
• W2280747130 hasConcept C71924100 @default.
• W2280747130 hasConcept C86803240 @default.
• W2280747130 hasConcept C98638677 @default.
• W2280747130 hasConcept C99454951 @default.
• W2280747130 hasConceptScore W2280747130C104317684 @default.
• W2280747130 hasConceptScore W2280747130C121608353 @default.
• W2280747130 hasConceptScore W2280747130C126322002 @default.
• W2280747130 hasConceptScore W2280747130C142724271 @default.
• W2280747130 hasConceptScore W2280747130C18823058 @default.
• W2280747130 hasConceptScore W2280747130C204232928 @default.
• W2280747130 hasConceptScore W2280747130C2776256026 @default.
• W2280747130 hasConceptScore W2280747130C2781182431 @default.
• W2280747130 hasConceptScore W2280747130C2908647359 @default.
• W2280747130 hasConceptScore W2280747130C501734568 @default.
• W2280747130 hasConceptScore W2280747130C54355233 @default.
• W2280747130 hasConceptScore W2280747130C71924100 @default.
• W2280747130 hasConceptScore W2280747130C86803240 @default.
• W2280747130 hasConceptScore W2280747130C98638677 @default.
• W2280747130 hasConceptScore W2280747130C99454951 @default.
• W2280747130 hasIssue "7" @default.
• W2280747130 hasLocation W22807471301 @default.
• W2280747130 hasOpenAccess W2280747130 @default.
• W2280747130 hasPrimaryLocation W22807471301 @default.
• W2280747130 hasRelatedWork W2339326149 @default.
• W2280747130 hasRelatedWork W2349337108 @default.
• W2280747130 hasRelatedWork W2353108337 @default.
• W2280747130 hasRelatedWork W2355005742 @default.
• W2280747130 hasRelatedWork W2378830451 @default.
• W2280747130 hasRelatedWork W2406191540 @default.
• W2280747130 hasRelatedWork W2967807857 @default.
• W2280747130 hasRelatedWork W3200167754 @default.
• W2280747130 hasRelatedWork W43739142 @default.
• W2280747130 hasRelatedWork W2189386093 @default.
• W2280747130 hasVolume "36" @default.
• W2280747130 isParatext "false" @default.
• W2280747130 isRetracted "false" @default.
• W2280747130 magId "2280747130" @default.
• W2280747130 workType "article" @default.